Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters

Abstract Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista latino-americana de enfermagem 2022, Vol.30
Hauptverfasser: Barros, Daniele Porto, Onofre, Priscilla Sete de Carvalho, Fonseca, Fernando Luiz Affonso, Rosa, Paulo César Pires, Pedreira, Mavilde da Luz Gonçalves, Peterlini, Maria Angélica Sorgini
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Revista latino-americana de enfermagem
container_volume 30
creator Barros, Daniele Porto
Onofre, Priscilla Sete de Carvalho
Fonseca, Fernando Luiz Affonso
Rosa, Paulo César Pires
Pedreira, Mavilde da Luz Gonçalves
Peterlini, Maria Angélica Sorgini
description Abstract Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration by means of high-efficiency liquid chromatography of vancomycin hydrochloride (n=06) and vancomycin hydrochloride and heparin sodium (n=06). The solutions studied were submitted to absence of light, as well as to 22°C and 37°C. Analyses in triplicate (n=192) were performed at the initial moment (T0) and three (T3), eight (T8) and 24 hours (T24) after preparation. The data were submitted to analysis of variance (p≤0.05). Results: concentration of the antimicrobial at 22°C presented a reduction (T0-T8) and a subsequent increase (T24); hydrogenionic potential decreased significantly over time. At 37°C, the concentration increased up to T3 and decreased at T24, with a reduction of hydrogenionic potential up to 24 hours. Concentration of the vancomycin hydrochloride and heparin sodium solutions varied with a reduction at 22°C, accompanied by increased hydrogenionic potential. Precipitate formation was observed by visual inspection of the vancomycin hydrochloride-heparin sodium association (T3). Conclusion: pharmacological stability of vancomycin hydrochloride (5 mg/mL) and physical incompatibility with heparin sodium (100 IU/mL) were evidenced after three hours of association in the antimicrobial seal solutions studied. Resumo Objetivo: verificar a estabilidade do cloridrato de vancomicina em soluções de selo antimicrobiano sem e com associação de heparina sódica segundo a temperatura e tempo de associação. Método: estudo experimental delineado para análise de potencial hidrogeniônico e concentração por cromatografia líquida de alta eficiência de soluções de cloridrato de vancomicina (n=06) e cloridrato de vancomicina e heparina sódica (n=06). Submeteram-se as soluções estudadas à ausência de luz, 22°C e 37°C. Análises em triplicadas (n=192) ocorreram no momento inicial (T0), três (T3), oito (T8) e 24 horas (T24) após preparo. Os dados foram submetidos à análise de variância (p≤0,05). Resultados: a concentração do antimicrobiano a 22°C apresentou redução (T0-T8) e posterior elevação (T24); o potencial hidrogeniônico diminuiu significativamente ao longo do tempo. Em 37°C a concentração aumentou em até T3 e reduziu em T24, com redução de potencial hidrogeniônico até 24
doi_str_mv 10.1590/1518.8345.5869.3621
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2718755341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718755341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1171-eac0b1ec894addc472eb83b6c87d35c080b480512729ea55ec2dde8fd9a4f4383</originalsourceid><addsrcrecordid>eNpNkE9LxDAQxYMouK5-Ai8Fz62ZptmmR1n8Bwse1HNIkymbpW3WJF3ot7dhPXiZN7x5zDA_Qu6BFsAb-ggcRCFYxQsuNk3BNiVckFVy8-Re_uuvyU0IB0rLBiisiPuMqrW9jXPmuuykRu2GWdsx28_GO73vnbcGMxyOvZvRZMtEjdEOVnvXWtVnAVNx_RStG0NaonGMfjFtkhOObgqZVnGPEX24JVed6gPe_emafL88f23f8t3H6_v2aZdrgBpyVJq2gFo0lTJGV3WJrWDtRovaMK6poG0lKIeyLhtUnKMujUHRmUZVXcUEW5OH896jdz8ThigPbvLjclKWNYiac1bBkmLn1PJNCB47efR2UH6WQGUiKxM3mbjJRFYmsuwX3Idu7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718755341</pqid></control><display><type>article</type><title>Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Barros, Daniele Porto ; Onofre, Priscilla Sete de Carvalho ; Fonseca, Fernando Luiz Affonso ; Rosa, Paulo César Pires ; Pedreira, Mavilde da Luz Gonçalves ; Peterlini, Maria Angélica Sorgini</creator><creatorcontrib>Barros, Daniele Porto ; Onofre, Priscilla Sete de Carvalho ; Fonseca, Fernando Luiz Affonso ; Rosa, Paulo César Pires ; Pedreira, Mavilde da Luz Gonçalves ; Peterlini, Maria Angélica Sorgini</creatorcontrib><description>Abstract Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration by means of high-efficiency liquid chromatography of vancomycin hydrochloride (n=06) and vancomycin hydrochloride and heparin sodium (n=06). The solutions studied were submitted to absence of light, as well as to 22°C and 37°C. Analyses in triplicate (n=192) were performed at the initial moment (T0) and three (T3), eight (T8) and 24 hours (T24) after preparation. The data were submitted to analysis of variance (p≤0.05). Results: concentration of the antimicrobial at 22°C presented a reduction (T0-T8) and a subsequent increase (T24); hydrogenionic potential decreased significantly over time. At 37°C, the concentration increased up to T3 and decreased at T24, with a reduction of hydrogenionic potential up to 24 hours. Concentration of the vancomycin hydrochloride and heparin sodium solutions varied with a reduction at 22°C, accompanied by increased hydrogenionic potential. Precipitate formation was observed by visual inspection of the vancomycin hydrochloride-heparin sodium association (T3). Conclusion: pharmacological stability of vancomycin hydrochloride (5 mg/mL) and physical incompatibility with heparin sodium (100 IU/mL) were evidenced after three hours of association in the antimicrobial seal solutions studied. Resumo Objetivo: verificar a estabilidade do cloridrato de vancomicina em soluções de selo antimicrobiano sem e com associação de heparina sódica segundo a temperatura e tempo de associação. Método: estudo experimental delineado para análise de potencial hidrogeniônico e concentração por cromatografia líquida de alta eficiência de soluções de cloridrato de vancomicina (n=06) e cloridrato de vancomicina e heparina sódica (n=06). Submeteram-se as soluções estudadas à ausência de luz, 22°C e 37°C. Análises em triplicadas (n=192) ocorreram no momento inicial (T0), três (T3), oito (T8) e 24 horas (T24) após preparo. Os dados foram submetidos à análise de variância (p≤0,05). Resultados: a concentração do antimicrobiano a 22°C apresentou redução (T0-T8) e posterior elevação (T24); o potencial hidrogeniônico diminuiu significativamente ao longo do tempo. Em 37°C a concentração aumentou em até T3 e reduziu em T24, com redução de potencial hidrogeniônico até 24 horas. A concentração das soluções de cloridrato de vancomicina e heparina sódica apresentaram variação com redução a 22°C acompanhada de aumento de potencial hidrogeniônico. Observou-se formação de precipitado por inspeção visual da associação cloridrato de vancomicina e heparina sódica (T3). Conclusão: evidenciou-se estabilidade farmacológica do cloridrato de vancomicina (5 mg/mL) e incompatibilidade física com heparina sódica (100 UI/mL) após três horas de associação nas soluções de selo antimicrobiano estudadas. Resumen Objetivo: verificar la estabilidad del clorhidrato de vancomicina en soluciones de sellado antimicrobiano solo y combinado con heparina sódica según la temperatura y el tiempo de combinación. Método: estudio experimental diseñado para analizar el potencial de hidrógeno y la concentración por cromatografía líquida de alta resolución de soluciones de clorhidrato de vancomicina (n=06) y de clorhidrato de vancomicina y heparina sódica (n=06). Las soluciones estudiadas fueron sometidas a ausencia de luz, 22°C y 37°C. Se realizaron análisis por triplicado (n=192) en el momento inicial (T0), a las tres (T3), ocho (T8) y 24 horas (T24) después de la preparación. Los datos fueron sometidos a análisis de varianza (p≤0,05). Resultados: la concentración de antimicrobiano a 22°C mostró una reducción (T0-T8) y un posterior aumento (T24); el potencial de hidrógeno disminuyó significativamente con el tiempo. A 37°C, la concentración aumentó hasta T3 y disminuyó en T24, el potencial de hidrógeno disminuyó hasta las 24 horas. La concentración de las soluciones de clorhidrato de vancomicina y heparina sódica mostró variación con la reducción a 22°C acompañada de un aumento del potencial de hidrógeno. Mediante inspección visual se observó la formación de un precipitado al combinar clorhidrato de vancomicina y heparina sódica (T3). Conclusión: el clorhidrato de vancomicina (5 mg/ml) presentó evidencia de estabilidad farmacológica e incompatibilidad física con la heparina sódica (100 UI/ml) después de las tres horas de haberse realizado la combinación en las soluciones de sellado antimicrobiano estudiadas.</description><identifier>ISSN: 1518-8345</identifier><identifier>ISSN: 0104-1169</identifier><identifier>EISSN: 1518-8345</identifier><identifier>DOI: 10.1590/1518.8345.5869.3621</identifier><language>eng</language><publisher>Sao Paulo: Universidade de São Paulo-USP, Escola de Enfermagem de Ribeirão Preto - USP</publisher><subject>Antibiotics ; Anticoagulants ; Antimicrobial agents ; Catheters ; Disease prevention ; Intravenous therapy ; Sodium</subject><ispartof>Revista latino-americana de enfermagem, 2022, Vol.30</ispartof><rights>2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1171-eac0b1ec894addc472eb83b6c87d35c080b480512729ea55ec2dde8fd9a4f4383</cites><orcidid>0000-0003-1769-4662 ; 0000-0003-3665-8878 ; 0000-0002-4388-3793 ; 0000-0002-8830-0993 ; 0000-0002-9246-2354 ; 0000-0003-1223-1589</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Barros, Daniele Porto</creatorcontrib><creatorcontrib>Onofre, Priscilla Sete de Carvalho</creatorcontrib><creatorcontrib>Fonseca, Fernando Luiz Affonso</creatorcontrib><creatorcontrib>Rosa, Paulo César Pires</creatorcontrib><creatorcontrib>Pedreira, Mavilde da Luz Gonçalves</creatorcontrib><creatorcontrib>Peterlini, Maria Angélica Sorgini</creatorcontrib><title>Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters</title><title>Revista latino-americana de enfermagem</title><description>Abstract Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration by means of high-efficiency liquid chromatography of vancomycin hydrochloride (n=06) and vancomycin hydrochloride and heparin sodium (n=06). The solutions studied were submitted to absence of light, as well as to 22°C and 37°C. Analyses in triplicate (n=192) were performed at the initial moment (T0) and three (T3), eight (T8) and 24 hours (T24) after preparation. The data were submitted to analysis of variance (p≤0.05). Results: concentration of the antimicrobial at 22°C presented a reduction (T0-T8) and a subsequent increase (T24); hydrogenionic potential decreased significantly over time. At 37°C, the concentration increased up to T3 and decreased at T24, with a reduction of hydrogenionic potential up to 24 hours. Concentration of the vancomycin hydrochloride and heparin sodium solutions varied with a reduction at 22°C, accompanied by increased hydrogenionic potential. Precipitate formation was observed by visual inspection of the vancomycin hydrochloride-heparin sodium association (T3). Conclusion: pharmacological stability of vancomycin hydrochloride (5 mg/mL) and physical incompatibility with heparin sodium (100 IU/mL) were evidenced after three hours of association in the antimicrobial seal solutions studied. Resumo Objetivo: verificar a estabilidade do cloridrato de vancomicina em soluções de selo antimicrobiano sem e com associação de heparina sódica segundo a temperatura e tempo de associação. Método: estudo experimental delineado para análise de potencial hidrogeniônico e concentração por cromatografia líquida de alta eficiência de soluções de cloridrato de vancomicina (n=06) e cloridrato de vancomicina e heparina sódica (n=06). Submeteram-se as soluções estudadas à ausência de luz, 22°C e 37°C. Análises em triplicadas (n=192) ocorreram no momento inicial (T0), três (T3), oito (T8) e 24 horas (T24) após preparo. Os dados foram submetidos à análise de variância (p≤0,05). Resultados: a concentração do antimicrobiano a 22°C apresentou redução (T0-T8) e posterior elevação (T24); o potencial hidrogeniônico diminuiu significativamente ao longo do tempo. Em 37°C a concentração aumentou em até T3 e reduziu em T24, com redução de potencial hidrogeniônico até 24 horas. A concentração das soluções de cloridrato de vancomicina e heparina sódica apresentaram variação com redução a 22°C acompanhada de aumento de potencial hidrogeniônico. Observou-se formação de precipitado por inspeção visual da associação cloridrato de vancomicina e heparina sódica (T3). Conclusão: evidenciou-se estabilidade farmacológica do cloridrato de vancomicina (5 mg/mL) e incompatibilidade física com heparina sódica (100 UI/mL) após três horas de associação nas soluções de selo antimicrobiano estudadas. Resumen Objetivo: verificar la estabilidad del clorhidrato de vancomicina en soluciones de sellado antimicrobiano solo y combinado con heparina sódica según la temperatura y el tiempo de combinación. Método: estudio experimental diseñado para analizar el potencial de hidrógeno y la concentración por cromatografía líquida de alta resolución de soluciones de clorhidrato de vancomicina (n=06) y de clorhidrato de vancomicina y heparina sódica (n=06). Las soluciones estudiadas fueron sometidas a ausencia de luz, 22°C y 37°C. Se realizaron análisis por triplicado (n=192) en el momento inicial (T0), a las tres (T3), ocho (T8) y 24 horas (T24) después de la preparación. Los datos fueron sometidos a análisis de varianza (p≤0,05). Resultados: la concentración de antimicrobiano a 22°C mostró una reducción (T0-T8) y un posterior aumento (T24); el potencial de hidrógeno disminuyó significativamente con el tiempo. A 37°C, la concentración aumentó hasta T3 y disminuyó en T24, el potencial de hidrógeno disminuyó hasta las 24 horas. La concentración de las soluciones de clorhidrato de vancomicina y heparina sódica mostró variación con la reducción a 22°C acompañada de un aumento del potencial de hidrógeno. Mediante inspección visual se observó la formación de un precipitado al combinar clorhidrato de vancomicina y heparina sódica (T3). Conclusión: el clorhidrato de vancomicina (5 mg/ml) presentó evidencia de estabilidad farmacológica e incompatibilidad física con la heparina sódica (100 UI/ml) después de las tres horas de haberse realizado la combinación en las soluciones de sellado antimicrobiano estudiadas.</description><subject>Antibiotics</subject><subject>Anticoagulants</subject><subject>Antimicrobial agents</subject><subject>Catheters</subject><subject>Disease prevention</subject><subject>Intravenous therapy</subject><subject>Sodium</subject><issn>1518-8345</issn><issn>0104-1169</issn><issn>1518-8345</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpNkE9LxDAQxYMouK5-Ai8Fz62ZptmmR1n8Bwse1HNIkymbpW3WJF3ot7dhPXiZN7x5zDA_Qu6BFsAb-ggcRCFYxQsuNk3BNiVckFVy8-Re_uuvyU0IB0rLBiisiPuMqrW9jXPmuuykRu2GWdsx28_GO73vnbcGMxyOvZvRZMtEjdEOVnvXWtVnAVNx_RStG0NaonGMfjFtkhOObgqZVnGPEX24JVed6gPe_emafL88f23f8t3H6_v2aZdrgBpyVJq2gFo0lTJGV3WJrWDtRovaMK6poG0lKIeyLhtUnKMujUHRmUZVXcUEW5OH896jdz8ThigPbvLjclKWNYiac1bBkmLn1PJNCB47efR2UH6WQGUiKxM3mbjJRFYmsuwX3Idu7Q</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Barros, Daniele Porto</creator><creator>Onofre, Priscilla Sete de Carvalho</creator><creator>Fonseca, Fernando Luiz Affonso</creator><creator>Rosa, Paulo César Pires</creator><creator>Pedreira, Mavilde da Luz Gonçalves</creator><creator>Peterlini, Maria Angélica Sorgini</creator><general>Universidade de São Paulo-USP, Escola de Enfermagem de Ribeirão Preto - USP</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0003-1769-4662</orcidid><orcidid>https://orcid.org/0000-0003-3665-8878</orcidid><orcidid>https://orcid.org/0000-0002-4388-3793</orcidid><orcidid>https://orcid.org/0000-0002-8830-0993</orcidid><orcidid>https://orcid.org/0000-0002-9246-2354</orcidid><orcidid>https://orcid.org/0000-0003-1223-1589</orcidid></search><sort><creationdate>2022</creationdate><title>Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters</title><author>Barros, Daniele Porto ; Onofre, Priscilla Sete de Carvalho ; Fonseca, Fernando Luiz Affonso ; Rosa, Paulo César Pires ; Pedreira, Mavilde da Luz Gonçalves ; Peterlini, Maria Angélica Sorgini</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1171-eac0b1ec894addc472eb83b6c87d35c080b480512729ea55ec2dde8fd9a4f4383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Anticoagulants</topic><topic>Antimicrobial agents</topic><topic>Catheters</topic><topic>Disease prevention</topic><topic>Intravenous therapy</topic><topic>Sodium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barros, Daniele Porto</creatorcontrib><creatorcontrib>Onofre, Priscilla Sete de Carvalho</creatorcontrib><creatorcontrib>Fonseca, Fernando Luiz Affonso</creatorcontrib><creatorcontrib>Rosa, Paulo César Pires</creatorcontrib><creatorcontrib>Pedreira, Mavilde da Luz Gonçalves</creatorcontrib><creatorcontrib>Peterlini, Maria Angélica Sorgini</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Revista latino-americana de enfermagem</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barros, Daniele Porto</au><au>Onofre, Priscilla Sete de Carvalho</au><au>Fonseca, Fernando Luiz Affonso</au><au>Rosa, Paulo César Pires</au><au>Pedreira, Mavilde da Luz Gonçalves</au><au>Peterlini, Maria Angélica Sorgini</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters</atitle><jtitle>Revista latino-americana de enfermagem</jtitle><date>2022</date><risdate>2022</risdate><volume>30</volume><issn>1518-8345</issn><issn>0104-1169</issn><eissn>1518-8345</eissn><abstract>Abstract Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration by means of high-efficiency liquid chromatography of vancomycin hydrochloride (n=06) and vancomycin hydrochloride and heparin sodium (n=06). The solutions studied were submitted to absence of light, as well as to 22°C and 37°C. Analyses in triplicate (n=192) were performed at the initial moment (T0) and three (T3), eight (T8) and 24 hours (T24) after preparation. The data were submitted to analysis of variance (p≤0.05). Results: concentration of the antimicrobial at 22°C presented a reduction (T0-T8) and a subsequent increase (T24); hydrogenionic potential decreased significantly over time. At 37°C, the concentration increased up to T3 and decreased at T24, with a reduction of hydrogenionic potential up to 24 hours. Concentration of the vancomycin hydrochloride and heparin sodium solutions varied with a reduction at 22°C, accompanied by increased hydrogenionic potential. Precipitate formation was observed by visual inspection of the vancomycin hydrochloride-heparin sodium association (T3). Conclusion: pharmacological stability of vancomycin hydrochloride (5 mg/mL) and physical incompatibility with heparin sodium (100 IU/mL) were evidenced after three hours of association in the antimicrobial seal solutions studied. Resumo Objetivo: verificar a estabilidade do cloridrato de vancomicina em soluções de selo antimicrobiano sem e com associação de heparina sódica segundo a temperatura e tempo de associação. Método: estudo experimental delineado para análise de potencial hidrogeniônico e concentração por cromatografia líquida de alta eficiência de soluções de cloridrato de vancomicina (n=06) e cloridrato de vancomicina e heparina sódica (n=06). Submeteram-se as soluções estudadas à ausência de luz, 22°C e 37°C. Análises em triplicadas (n=192) ocorreram no momento inicial (T0), três (T3), oito (T8) e 24 horas (T24) após preparo. Os dados foram submetidos à análise de variância (p≤0,05). Resultados: a concentração do antimicrobiano a 22°C apresentou redução (T0-T8) e posterior elevação (T24); o potencial hidrogeniônico diminuiu significativamente ao longo do tempo. Em 37°C a concentração aumentou em até T3 e reduziu em T24, com redução de potencial hidrogeniônico até 24 horas. A concentração das soluções de cloridrato de vancomicina e heparina sódica apresentaram variação com redução a 22°C acompanhada de aumento de potencial hidrogeniônico. Observou-se formação de precipitado por inspeção visual da associação cloridrato de vancomicina e heparina sódica (T3). Conclusão: evidenciou-se estabilidade farmacológica do cloridrato de vancomicina (5 mg/mL) e incompatibilidade física com heparina sódica (100 UI/mL) após três horas de associação nas soluções de selo antimicrobiano estudadas. Resumen Objetivo: verificar la estabilidad del clorhidrato de vancomicina en soluciones de sellado antimicrobiano solo y combinado con heparina sódica según la temperatura y el tiempo de combinación. Método: estudio experimental diseñado para analizar el potencial de hidrógeno y la concentración por cromatografía líquida de alta resolución de soluciones de clorhidrato de vancomicina (n=06) y de clorhidrato de vancomicina y heparina sódica (n=06). Las soluciones estudiadas fueron sometidas a ausencia de luz, 22°C y 37°C. Se realizaron análisis por triplicado (n=192) en el momento inicial (T0), a las tres (T3), ocho (T8) y 24 horas (T24) después de la preparación. Los datos fueron sometidos a análisis de varianza (p≤0,05). Resultados: la concentración de antimicrobiano a 22°C mostró una reducción (T0-T8) y un posterior aumento (T24); el potencial de hidrógeno disminuyó significativamente con el tiempo. A 37°C, la concentración aumentó hasta T3 y disminuyó en T24, el potencial de hidrógeno disminuyó hasta las 24 horas. La concentración de las soluciones de clorhidrato de vancomicina y heparina sódica mostró variación con la reducción a 22°C acompañada de un aumento del potencial de hidrógeno. Mediante inspección visual se observó la formación de un precipitado al combinar clorhidrato de vancomicina y heparina sódica (T3). Conclusión: el clorhidrato de vancomicina (5 mg/ml) presentó evidencia de estabilidad farmacológica e incompatibilidad física con la heparina sódica (100 UI/ml) después de las tres horas de haberse realizado la combinación en las soluciones de sellado antimicrobiano estudiadas.</abstract><cop>Sao Paulo</cop><pub>Universidade de São Paulo-USP, Escola de Enfermagem de Ribeirão Preto - USP</pub><doi>10.1590/1518.8345.5869.3621</doi><orcidid>https://orcid.org/0000-0003-1769-4662</orcidid><orcidid>https://orcid.org/0000-0003-3665-8878</orcidid><orcidid>https://orcid.org/0000-0002-4388-3793</orcidid><orcidid>https://orcid.org/0000-0002-8830-0993</orcidid><orcidid>https://orcid.org/0000-0002-9246-2354</orcidid><orcidid>https://orcid.org/0000-0003-1223-1589</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1518-8345
ispartof Revista latino-americana de enfermagem, 2022, Vol.30
issn 1518-8345
0104-1169
1518-8345
language eng
recordid cdi_proquest_journals_2718755341
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Antibiotics
Anticoagulants
Antimicrobial agents
Catheters
Disease prevention
Intravenous therapy
Sodium
title Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stability%20of%20vancomycin%20hydrochloride%20employed%20in%20antimicrobial%20seal%20solutions%20of%20central%20intravenous%20catheters&rft.jtitle=Revista%20latino-americana%20de%20enfermagem&rft.au=Barros,%20Daniele%20Porto&rft.date=2022&rft.volume=30&rft.issn=1518-8345&rft.eissn=1518-8345&rft_id=info:doi/10.1590/1518.8345.5869.3621&rft_dat=%3Cproquest_cross%3E2718755341%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718755341&rft_id=info:pmid/&rfr_iscdi=true